financetom
Business
financetom
/
Business
/
Old National Bancorp strikes $1.4 bln deal for Bremer Financial
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Old National Bancorp strikes $1.4 bln deal for Bremer Financial
Nov 25, 2024 4:32 AM

Nov 25 (Reuters) - Regional lender Old National Bancorp ( ONB )

said on Monday it will buy privately held Bremer

Financial in a $1.40 billion cash-and-stock deal, creating a

combined bank with over $70 billion in assets.

Bremer shareholders will receive 4.182 shares of Old

National and $26.22 in cash, valuing the lender at $116.76 per

share.

Dealmaking between regional lenders has surged this year as

they seek scale to better compete against bigger rivals, and is

expected to get a further boost from President-elect Donald

Trump's lenient stance on capital rules and merger approvals.

The Bremer deal will bolster Old National's footprint in

Minnesota, North Dakota and Wisconsin.

Founded in 1943, Minnesota-based Bremer has $16.2 billion in

assets, while Indiana-based Old National has about $54 billion.

Bremer is majority owned by the Otto Bremer Trust, which

will own about 11% of Old National upon the deal close.

Citi and Squire Patton Boggs were the advisers to Old

National. J.P. Morgan and Wachtell, Lipton, Rosen & Katz advised

Bremer.

Keefe, Bruyette & Woods and Sullivan & Cromwell advised Otto

Bremer Trust.

Separately, Old National sold 19 million shares in a stock

offering at $21 each for $400 million.

(Reporting by Arasu Kannagi Basil in Bengaluru; Editing by

Krishna Chandra Eluri and Shinjini Ganguli)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Looming trade tariffs have yet to hit demand for flights, Walsh says
Looming trade tariffs have yet to hit demand for flights, Walsh says
Apr 1, 2025
LONDON (Reuters) - The head of global airlines body IATA said threatened U.S. trade tariffs were unlikely to halt a post-COVID surge in travel demand, and that President Donald Trump's approach could ultimately be positive for the industry. It's additional uncertainty which we never welcome but we've always been able to manage, IATA's Willie Walsh said in an interview, as...
Boralex Commences Operations at Flagship Wind Farm in Scotland
Boralex Commences Operations at Flagship Wind Farm in Scotland
Apr 1, 2025
09:06 AM EDT, 04/01/2025 (MT Newswires) -- Boralex ( BRLXF ) on Tuesday said the 106-MW Limekiln wind farm in the U.K. and all its turbines are now operational. The wind farm is Boralex's ( BRLXF ) flagship project in Scotland and its first operational site in the U.K. The U.K. is a key geography in achieving our growth and...
CenterPoint Energy Finalizes Sale of Louisiana and Mississippi Gas Utilities to Bernhard Capital Partners
CenterPoint Energy Finalizes Sale of Louisiana and Mississippi Gas Utilities to Bernhard Capital Partners
Apr 1, 2025
09:05 AM EDT, 04/01/2025 (MT Newswires) -- CenterPoint Energy ( CNP ) said Tuesday it completed the sale of its natural gas distribution utilities in Louisiana and Mississippi to affiliates of Bernhard Capital Partners. The utility company previously said in February 2024 it was selling the businesses to the private equity firm for $1.2 billion. The company said the assets...
Apellis Pharmaceuticals Says US FDA Grants Priority Review to Empaveli Application for Rare Kidney Diseases
Apellis Pharmaceuticals Says US FDA Grants Priority Review to Empaveli Application for Rare Kidney Diseases
Apr 1, 2025
09:05 AM EDT, 04/01/2025 (MT Newswires) -- Apellis Pharmaceuticals ( APLS ) said Tuesday that the US Food and Drug Administration has accepted its supplemental new drug application for Empaveli, or pegcetacoplan, to treat C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis, both rare kidney diseases. The company said the application is based on results from a late-stage trial that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved